Cumberland Pharmaceuticals Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 600.00 shares.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 600.00 shares 10-K · filed 2026-03-09 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-09 | |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-07 | |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-13 | |
| 2020-12-31 | 0.00 shares 10-K · filed 2021-03-12 | |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-12 | |
| 2018-12-31 | 0.00 shares 8-K · filed 2020-12-10 | |
| 2017-12-31 | 0.00 shares 10-K · filed 2019-03-12 | |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-09 | |
| 2015-12-31 | 5.65K shares 10-K · filed 2017-03-13 | |
| 2014-12-31 | 0.00 shares 10-K · filed 2016-03-14 | |
| 2013-12-31 | 171.10K shares 10-K · filed 2015-03-09 | |
| 2012-12-31 | 173.69K shares 10-K · filed 2014-03-11 | |
| 2011-12-31 | 503.41K shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |